Leverage synthetic data to propel personalized medicine to new heights: Launching SYNTHIA, a pioneering public-private partnership funded by the Innovative Health Initiative

Press release

Under construction..

Join us on this journey to propel personalized medicine to new heights!



About SYNTHIA: Synthetic Data Generation framework for integrated validation of use cases and AI healthcare applications
SYNTHIA is a pioneering public-private partnership leveraging synthetic data to propel personalized medicine to new heights. This project is funded by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101172872. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, EuropaBio, MedTech Europe, and Vaccines Europe and DNV. Supported by the European Union’s Horizon Europe research and innovation program and industry leaders such as COCIR, EFPIA, EuropaBio, MedTech Europe, Vaccines Europe, and DNV, SYNTHIA is dedicated to advancing synthetic data generation for healthcare applications, ensuring that data-driven innovations can safely and effectively transform patient care.